Michael Klein, Chairman of the Board, to serve as Executive Chairman and Interim CEO

NASHUA, N.H., (November 9, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Ken Ferry has retired from his position as Chief Executive Officer (CEO) and stepped down as a Director of the Company, effective immediately. Michael Klein, Chairman of iCAD’s Bo... Continue reading

Prominent medical center is first in the United States to expand breast health offerings with iCAD’s PowerLook Tomo Detection solution and Xoft System

NASHUA, N.H., and Macon, GA, (October 30, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its complete suite of leading-edge breast health innovations including PowerLook® Tomo Detection,&... Continue reading

Multi-center research presented at ASTRO 2018 shows IORT with the Xoft System is safe with low recurrence and low morbidity in the treatment of breast cancer

Company marks 20 years of innovations in targeted cancer care at the conference

NASHUA, N.H. and SAN ANTONIO, Texas (Booth #3457)... Continue reading

For more than 100 years, radiation has been used to reduce the recurrence of cancer and improve survival. While this treatment option presents important benefits, traditional radiation therapy has significant side effects for patients.

Today, there are several innovative technologies on the market that provide valuable health benefits as well as time and cost savings for patients. One such technology is intraoperative radiation therap... Continue reading

Premier center becomes first in the region to offer intraoperative radiation therapy with the leading-edge Xoft System to advance quality patient care in New York State

NASHUA, N.H. and Syracuse, N.Y., (October 9, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its Xoft® Axxent® Electronic Brachytherapy (eBx®) System®... Continue reading

Medical facility becomes first in South Dakota to offer intraoperative radiation therapy with the revolutionary Xoft System to improve patient care

NASHUA, N.H. and SIOUX FALLS, S.D., (October 3, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the availability of the company’s Xoft® Axxent®Electronic Brachytherapy (eBx®) System® at Sanford USD Medical... Continue reading

Retrospective trial utilizing intraoperative radiation therapy with the revolutionary Xoft System shows recurrence rates to be comparable to cornerstone TARGIT-A Trial at mean follow-up 4.6 years

NASHUA, N.H., (October 1, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the results of a long-term, independent study conducted with the Xoft® Axxent®... Continue reading

First installation of versatile, multi-platform Xoft System in India demonstrates strong, continued momentum in global commercialization of electronic brachytherapy (eBx)

Nashua, N.H. and Hyderabad, India, (August 29, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, announced today that its Xoft® Axxent® Electronic Brachytherapy (eBx®) System® has received an Atomic Energy Regula... Continue reading

Leading center becomes first in Texas to offer intraoperative radiation therapy with the advanced Xoft System to enhance patient care

NASHUA, N.H. and Plano, Texas, (August 28, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is now available at Medical City Plano. Operated by HCA Healthcare, the world-class medical facility in Plano, Texas is the first in the state to... Continue reading

Did you know that every year in the U.S. more than 60,000 women are diagnosed with early-stage breast cancer? These numbers are daunting, but there are innovative technologies in the marketplace today that not only lower costs for patients and the overall U.S. healthcare system, but also provide patients with increased treatment alternatives.

Our team recently released findings of a Cost Effectiveness and Resource Allocation study that found intraoperative radiation therapy (IORT) to be the preferred treatment for early-stage breas... Continue reading

Did you know non-melanoma skin cancer (NMSC) affects more than three million people and kills 2,000 people each year?

But it doesn’t have to. If caught early, NMSC can be easily treated and have few negative consequences, however, it is critical to understand some of the main causes of NMSC, such as excessive exposure to ultraviolent rays (UVRs). With July being UV Safety Awareness Month, it’s the perfect time to discuss the impact of ultraviolent rays (UVRs) and how they affect your overal... Continue reading

Not only is May Skin Cancer Awareness Month, it’s also Ultraviolet Awareness Month, providing us with an invaluable opportunity to learn more about harmful ultraviolet rays (UVRs) and how we can protect our skin, even in the winter months.

First, some fast facts. According to the American Academy of Dermatology, it is estimated that approximately 9,500 people in the U.S. are diagnosed with skin cancer every day. This means more people are diagnosed with skin cancer each year in the U.S. than all other cancers combine... Continue reading

Alam M. Nisar Syed, MD, Medical Director Radiation Oncology & Endocurietherapy, MemorialCare Cancer Institute, Long Beach Memorial Medical Center (left) and Joyce Musacchio, Clinical Project Manager Xoft, a subsidiary of iCAD, Inc. (right) with the Category III Clinical winner at NCoBC 2018. Abstract, "A multi-center trial of intra-operative electronic brachytherapy during breast conservation surgery for early stage breast cancer: early results of unplanned boost participants."

Trade show season is here! While these events... Continue reading

Company to showcase advanced, multi-platform electronic brachytherapy (eBx) technology in booth 6800

Nashua, N.H. and Barcelona, Spain (ESTRO Booth 6800) (April 19, 2018) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that researchers from Hospital Universitario Miguel Servet in Zaragoza, Spain will pres... Continue reading

According to the American Cancer Society, last year alone there were an estimated 1,688,780 new cancer cases diagnosed and 600,920 cancer deaths in the U.S. These numbers are devastating, but are also why each of us at Xoft come to work every single day. In fact, our company was founded with the sole purpose of improving and expanding patient access to lifesaving treatm... Continue reading

A new clinical study shows how intraoperative radiation therapy (IORT) can reduce radiation side effects and save breast cancer patients ,500 annually.

It’s no surprise that spending on healthcare is rising faster than... Continue reading

No matter what time of year it is or where you live, harmful ultraviolet rays (UVRs) are present year-round, and are the primary cause of skin cancer. Surprisingly, more women are diagnosed with skin cancer each year than breast cancer. In fact, according to SkinCancer.org, over the past three decades, more people have had skin cancer than all other cancers combined.

Continue reading

Prominent cancer centers expand portfolio of patient-centric treatment solutions with Xoft’s innovative, painless, scar-free solution

NASHUA, N.H., (December 12, 2017) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions... Continue reading

Lifetime cost-effectiveness analysis reveals 0 million annual cost savings, less radiation exposure and better quality of life for patients compared to external beam radiation therapy

NASHUA, N.H., (December 7, 2017) – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the results of a landmark study that showed the bene... Continue reading

Skin cancer is the most common type of cancer in the U.S.

Many people are familiar with melanoma, which often appears as an irregular shaped mole, but non-melanoma skin cancer is the most common form of skin cancer. It af... Continue reading